Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-Current Debt (2018 - 2021)

Lipocine's Non-Current Debt history spans 4 years, with the latest figure at $1.4 million for Q1 2021.

  • For Q1 2021, Non-Current Debt fell 69.23% year-over-year to $1.4 million; the TTM value through Mar 2021 reached $1.4 million, down 69.23%, while the annual FY2020 figure was $2.3 million, 40.83% down from the prior year.
  • Non-Current Debt reached $1.4 million in Q1 2021 per LPCN's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $8.7 million in Q1 2018 to a low of $1.4 million in Q1 2021.
  • Average Non-Current Debt over 4 years is $5.2 million, with a median of $4.7 million recorded in 2020.
  • Peak YoY movement for Non-Current Debt: fell 23.9% in 2020, then tumbled 69.23% in 2021.
  • A 4-year view of Non-Current Debt shows it stood at $6.9 million in 2018, then crashed by 44.93% to $3.8 million in 2019, then plummeted by 40.83% to $2.3 million in 2020, then tumbled by 36.09% to $1.4 million in 2021.
  • Per Business Quant, the three most recent readings for LPCN's Non-Current Debt are $1.4 million (Q1 2021), $2.3 million (Q4 2020), and $3.2 million (Q3 2020).